<- Go home

Added to YB: 2023-12-18

Pitch date: 2023-12-18

TWST:US [bearish]

Twist Bioscience Corporation

+11.56%

current return

Author Info

No bio for this author

Company Info

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.

Market Cap

$1.6B

Pitch Price

$35.13

Price Target

N/A

Dividend

N/A

EV/EBITDA

-16.66

P/E

-20.69

EV/Sales

3.93

Sector

Biotechnology

Category

N/A

Show full summary:
Twist Bioscience Corp. TWST:US

A summary for this pitch has not been created yet.

Read full article (0 min)